Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion type Assertion NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_head.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion wasGeneratedBy ECO_0000203 NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_provenance.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion wasDerivedFrom befree-2016 NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_provenance.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion SIO_000772 18942640 NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_provenance.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion evidence source_evidence_literature NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_provenance.
- NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_assertion description "[The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699329.RA711ShwpyZY5U4gujq7pk3h0qjtnnXLSt1R4uxwjxhbg130_provenance.